Jason Hafler - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Jason Hafler’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Research and Development,
- Drug Discovery,
- Wellness,
- Women Founded,
- Rare Diseases,
- Healthcare Innovation,
- Life Science,
- Emerging Markets,
- Health Technology,
- Diabetes,
- Business Development,
- Mobile,
- Manufacturing,
- Biotechnology,
- Drug Development,
- Innovation,
- Neuroscience,
- Clinical Trials,
- Digital Transformation,
- Research,
- Vaccines,
- Personalized Medicine,
- Mergers and Acquisitions,
- Social Impact,
- Digital Health,
- Renewable Energy,
- Medical,
- Information Technology,
- B2B,
- Therapeutics,
- Molecular Diagnostics,
- Personal Health,
- Pharmaceuticals,
- Healthcare Technology,
- Acquisitions,
- Oncology
Social media:
Past investments:
- Proteostasis Therapeutics
- Sanofi Ventures
- Science 37
- ImmuneXcite
- Aetion
- NeuroVia
- Madgalene College Foundation
- Medisafe
- Lysosomal Therapeutics
- Sirtris Pharmaceuticals
- UNUM Therapeutics
- Beacon Hill Nursery School
- Immune Design
- Common Sensing
- GlycoMimetics
- NGI
- Yumanity Therapeutics
- KAHR medical
- Kymera Therapeutics
- Ovid Therapeutics
- Expansion Therapeutics
- Imbria Pharmaceuticals
- Cogent Biosciences
- Bluebird Bio
- Abcuro
- NodThera
- Fate Therapeutics
- Minervax
- Omada Health
- Selecta Biosciences
- Bowdoin College
- Edimer Pharmaceuticals
- Icosavax
- Navitor Pharmaceuticals
- DiCE Molecules
- Escient Pharmaceuticals
- Evidation Health
- Curisium
- Click Therapeutics
- Q32 Bio
- Veralox Therapeutics
- Lumena Pharmaceuticals
- Lava Therapeutics
- Inozyme
- i2o Therapeutics
- Buckingham, Browne & Nichols
Investor Profile
Jason Hafler is a Corporate Venture Capital based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Proteostasis Therapeutics, Sanofi Ventures, Science 37, ImmuneXcite, Aetion, NeuroVia, Madgalene College Foundation, Medisafe, Lysosomal Therapeutics, Sirtris Pharmaceuticals, UNUM Therapeutics, Beacon Hill Nursery School, Immune Design, Common Sensing, GlycoMimetics, NGI, Yumanity TherapeuticsKAHR medical, Kymera Therapeutics, Ovid Therapeutics, Expansion Therapeutics, Imbria Pharmaceuticals, Cogent Biosciences, Bluebird Bio, Abcuro, NodThera, Fate Therapeutics, Minervax, Omada Health, Selecta Biosciences, Bowdoin College, Edimer Pharmaceuticals, Icosavax, Navitor Pharmaceuticals, DiCE Molecules, Escient Pharmaceuticals, Evidation Health, Curisium, Click Therapeutics, Q32 Bio, Veralox Therapeutics, Lumena Pharmaceuticals, Lava Therapeutics, Inozyme, i2o Therapeutics, Buckingham, Browne & Nichols, . Over time, Jason Hafler has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Jason Hafler is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Drug Discovery, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Emerging Markets, Health Technology, Diabetes, Business Development, Mobile, Manufacturing, Biotechnology, Drug Development, Innovation, Neuroscience, Clinical Trials, Digital Transformation, Research, Vaccines, Personalized Medicine, Mergers and Acquisitions, Social Impact, Digital Health, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Personal Health, Pharmaceuticals, Healthcare Technology, Acquisitions, Oncology may find it worthwhile to explore potential connections with Jason Hafler, as their portfolio suggests a familiarity and interest in this area.
Understanding Jason Hafler’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
